Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Strattera Suicidal Thinking Data Is Of Little Clinical Significance, Lilly Consultants Say

This article was originally published in The Pink Sheet Daily

Executive Summary

Data analysis used as the basis for a public health advisory on Lilly’s Strattera in children and adolescents is unreliable, SUNY Upstate Medical University, Columbia University professors say.

You may also be interested in...



Strattera Cleared For Longer Use In ADHD Kids

Trial data could reassure doctors about treating as needed, Lilly says.

Strattera Cleared For Longer Use In ADHD Kids

Trial data could reassure doctors about treating as needed, Lilly says.

Shire/Noven Methypatch For ADHD To Be Reviewed By Psychopharm Committee

Companies seek indication for once-daily methylphenidate patch for the treatment of attention deficit/hyperactivity disorder in children ages six to 12 years.

Related Content

Topics

UsernamePublicRestriction

Register

PS061229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel